{"id":2756,"date":"2021-11-17T13:21:09","date_gmt":"2021-11-17T13:21:09","guid":{"rendered":"https:\/\/www.msd-belgium.be\/en\/?post_type=story&p=2756"},"modified":"2021-11-22T15:54:53","modified_gmt":"2021-11-22T15:54:53","slug":"taking-on-ebola","status":"publish","type":"story","link":"https:\/\/www.msd-belgium.be\/en\/stories\/taking-on-ebola\/","title":{"rendered":"Taking on Ebola"},"content":{"rendered":"\n
\n
\n \n \n Innovation<\/small>\n <\/a>\n \n \n

\n Taking on Ebola\n <\/h1>\n

How science and innovation fuel our efforts to help combat a deadly disease<\/p>\n <\/div>\n\n

\n

November 17, 2021<\/p>\n

\n

Share this article<\/p>\n

\n \nFacebook icon<\/title><\/svg>\n<\/a><\/p>\n

\n\n\n\n\t.st0{fill:#00857C;}\n\n\nX icon<\/title><\/svg>\n<\/a><\/p>\n

\n \nLinkedin icon<\/title><\/svg>\n<\/a><\/p>\n

\n \nEmail icon<\/title><\/svg>\n<\/a><\/p>\n <\/div>\n <\/div>\n\n
\n
\n
\n \n \n \n \n \"\"\n\n <\/picture>\n\n <\/figure>\n \n <\/div>\n <\/div>\n\n
\n
\n
\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n\n\n\n

Patients are our purpose. That\u2019s why we pursue the best science in our inventions and everything we do. Every breakthrough we create has the potential to build a healthier, more hopeful future for people everywhere.<\/p>\n\n\n\n

Our company is a health care leader in the fight against Ebola. Along with external collaborators from all sectors, our scientists are at the forefront of the response to outbreaks of this deadly disease as we continue to address this global health challenge. Ebola Zaire virus has had a devastating impact on the world and has proved itself to be a deadly and contagious disease, with a survival rate of 50%.<\/p>\n\n\n\n

MSD plays an important role in discovering and developing innovative medicines and vaccines to treat and help prevent infectious diseases. Global public health preparedness against future Ebola outbreaks requires advanced planning, system readiness for rapid deployment and collaboration and partnership between public and private entities around the world. Our partnerships with the World Health Organization (WHO) and other health partners around the globe are a crucial component of our commitment to helping save and improve lives.<\/p>\n\n\n\n

\u201cIt\u2019s something that we take incredibly seriously and with a great sense of urgency to make sure that we do everything we can to support the teams on the front lines,\u201d says Beth-Ann Coller, distinguished scientist, clinical research, MSD Vaccines.<\/p>\n\n\n\n

\n
\n

\n \u201cOur team works with a 24-7 mentality to help tackle these outbreaks.\u201d <\/h2>\n \n
\n

\n Beth-Ann Coller<\/strong>\n <\/p>\n <\/small>\n <\/div>\n <\/div>\n<\/div>\n\n\n\n

Safeguarding the future<\/h3>\n\n\n\n

In 2021, MSD established an agreement with UNICEF to create the world\u2019s first global Ebola stockpile, the result of breakthrough innovation and collaboration with four leading international health and humanitarian organizations across the world. The global stockpile will offer a critical, rapid-response tool to help combat future outbreaks of this highly contagious illness that is endemic in parts of Central and West Africa.<\/p>\n\n\n\n

\u201cIt has been our honor to collaborate with WHO, Gavi, UNICEF, the U.S. government and many others in getting to this point,\u201d says John Markels, Ph.D., president of MSD Vaccines. \u201cWhile there remains important work ahead, the stockpile is a new and powerful tool in supporting future outbreak preparedness and response efforts. This historic milestone demonstrates what\u2019s possible when partners come together to pursue a common purpose.\u201d<\/p>\n\n\n\n

\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

This level of collaboration continues to be needed for Ebola and other diseases. We remain committed to working in collaboration with WHO and other global and local health partners to support current and future outbreak response efforts.<\/p>\n\n\n\n

As seen in the most recent suspected outbreak in C\u00f4te d\u2019Ivoire declared in August 2021, our work continues. We will maintain our efforts for as long as needed.<\/p>\n<\/div>\n<\/div>\n\n\n\n

Watch the video<\/h3>\n\n\n\n
\n
\n \n \n\n \n \n
\n \n \n \n \n \n <\/picture>\n <\/span>\n